Vue transversale de la maladie
Migraine
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
1236 résultats correspondants
· 45 visibles sur cette page
dans le périmètre Migraine
Niveau clinique
Études et traitements 570
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Wrist-watch sensor device Étude non communiquée | Migraine | À vérifier | Non applicable | Actif | The purpose of this project is to provide a new framework for diagnosing a… À vérifier | ClinicalTrials.gov 2026-09-02 | Détail |
| Adrenomedullin NCT07451769 · Selective Activation of the Adrenomedullin Receptors in Migraine | Migraine | À vérifier | Non applicable | RECRUITING | Adrenomedullin is a neuropeptide implicated in the pathogenesis of migrain… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| BR005-036C NCT07792681 · Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in… | Migraine | À vérifier | Phase 2/3 | NOT_YET_RECRUITING | The purpose of this study is to compare the efficacy and safety of BR005-0… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| Brave-Mind — Behavioral Resources and Awareness for Veterans With Epi… NCT07792291 · NCT07792291 | Migraine | À vérifier | Non applicable | NOT_YET_RECRUITING | The current study will evaluate effectiveness of cognitive behavioral ther… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| Brief Interventions in Chronic Migraine NCT05979337 · NCT05979337 | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | COMPLETED | People with chronic migraine headaches face many challenges, including hig… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| Elismetrep (K-304) 2 mg NCT06848075 · A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K… | Migraine | À vérifier | Phase 2 | COMPLETED | This is a double-blind, randomized, multicenter, outpatient evaluation of… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| Static magnetic helmet NCT07584382 · The Effect of Static Magnetic Fields on Neuroinflammation in Migraine | Migraine | Immunomodulation · Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | We are conducting this research in individuals with migraines to find out… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| The Effects of Physiotherapy in Migraine NCT07657377 · NCT07657377 | Migraine | Traitement symptomatique | Non applicable | RECRUITING | The aim of this study is to investigate the effects of a physiotherapy pro… À vérifier | ClinicalTrials.gov 2026-09-01 09:22:10 | Détail |
| Cilostazol NCT03109288 · Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies… | Sclérose en plaques | À vérifier | Phase 1/2 | RECRUITING | In a double blind placebo-controlled cross-over study the effect of cilost… À vérifier | ClinicalTrials.gov 2026-09-01 09:21:54 | Détail |
| EVO756, Dose 2 Étude non communiquée | Migraine | À vérifier | Phase 2 | Actif | This study will evaluate the efficacy and safety of EVO756 against placebo… À vérifier | ClinicalTrials.gov 2026-09-01 | Détail |
| Stellate gangion blockade %1 5 mL Étude non communiquée | Migraine | Ralentissement de la progression · Traitement symptomatique | Non applicable | Terminé | Stellate Ganglion Block (SGB) is an interventional anesthetic technique us… À vérifier | ClinicalTrials.gov 2026-09-01 | Détail |
| Dexmedetomidine NCT07769255 · Effect of Nebulized Dexmedetomidine on Central Sensitization and Chronification… | Migraine | Traitement symptomatique · Thérapie génique | Non applicable | RECRUITING | Migraine is a debilitating neurological disorder characterized by recurren… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:25 | Détail |
| Active Remote Electrical Neuromodulation NCT07772427 · Neuromodulation During the Prodrome to Prevent Disabling Migraine Attacks in You… | Migraine | Traitement symptomatique | Non applicable | NOT_YET_RECRUITING | Background \& Rationale: One in ten Canadian youth have migraine, a disabl… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| HEAD-FLEX — Personalised Process-based Psychological Interventions fo… NCT07418723 · NCT07418723 | Migraine | Ralentissement de la progression | Non applicable | COMPLETED | This project was an empirical single-case experimental design (SCED) study… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Magnesium Sulfate 2 grams NCT07779486 · MAGHEAD — High- vs Standard-Dose Intravenous Magnesium for Acute Headache | Migraine | Ralentissement de la progression · Immunomodulation · Traitement symptomatique | Non applicable | RECRUITING | Headache is one of the most common reasons for consultation in emergency d… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Mechanism-Based Cervical Rehabilitation for Chronic Migraine NCT07762690 · NCT07762690 | Migraine | À vérifier | Non applicable | NOT_YET_RECRUITING | To investigate the effectiveness of mechanism-based cervical sensorimotor… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Rimegepant NCT07609914 · A Study to Learn About the Safety of Taking an Additional Dose of the Medicine R… | Migraine | À vérifier | Phase 4 | RECRUITING | The purpose of this study is to evaluate safety and tolerability of BHV-30… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Rimegepant 75 mg ODT NCT07685769 · A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India | Migraine | À vérifier | Phase 4 | RECRUITING | This is a multicenter, single-arm, open-label Phase 4 study evaluating the… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Ultrasound-guided pulsed radiofrequency (PRF) NCT07780136 · Comparison of the Effectiveness of Greater Occipital Nerve and Supratrochlear Ne… | Migraine | Ralentissement de la progression · Traitement symptomatique · Thérapie génique | Phase 4 | NOT_YET_RECRUITING | Migraine is a common chronic neurovascular disorder ranked among the leadi… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:24 | Détail |
| Cryoneurolysis NCT06554886 · A Study Investigating Peripheral Cryoneurolysis in Adults With Chronic Migraine | Migraine | Traitement symptomatique | Non applicable | ACTIVE_NOT_RECRUITING | The trial is a research study that tests a freezing technique called cryon… À vérifier | ClinicalTrials.gov 2026-08-26 14:49:23 | Détail |
Découverte scientifique
Recherches et trouvailles 0
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune trouvaille ne correspond aux filtres. | |||||||
Bibliographie
Publications 661
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Influence of Oliceridine on the Incidence of Postoperative Nausea and… Fentanyl · PMID 42446132 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source As a typical complication, postoperative nausea and vomiting (PONV) usually occurs among patients undergoing general an… | Journal of investigative surgery : the official journa… 2026-08-16 19:22:13 | Source |
| Real-life effectiveness, tolerability, and safety of atogepant: a pro… Atogepant 60 mg · PMID 42532410 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Migraine is the most frequent reason for neurology consultation and has a significant impact on patients at the profess… | Neurologia 2026-08-16 19:22:13 | Source |
| Sanctioning the supply chain: Analyzing US executive orders on tariff… Fentanyl · PMID 41954013 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source This commentary examines the use of trade tariffs embedded in U.S. executive orders issued during the Trump administrat… | Global public health 2026-08-16 19:22:13 | Source |
| Does Propofol-based or Remimazolam-based Anesthesia Impact the Incide… Metoclopramide 10 mg · PMID 41360105 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This study aimed to compare the incidence of postoperative nausea and vomiting (PONV) between propofol-based and remima… | Anesthesia progress 2026-08-16 19:22:12 | Source |
| IV dexamethasone as adjuvant therapy to metoclopramide for acute post… Metoclopramide 10 mg · PMID 41506783 | Migraine | Traitement symptomatique · Thérapie génique | Publication | PubMed | Voir la publication source We conducted a randomized study to determine if, among emergency department (ED) patients with acute posttraumatic head… | Headache 2026-08-16 19:22:12 | Source |
| Randomized controlled study of telcagepant plus ibuprofen or acetamin… Telcagepant 280 mg · PMID 21457238 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To evaluate the efficacy and tolerability of telcagepant when co-administered with ibuprofen or acetaminophen for the a… | Headache 2026-08-16 19:22:07 | Source |
| Randomized, controlled trial of telcagepant over four migraine attack… Telcagepant 140 mg · PMID 20974601 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source This study evaluated the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) fo… | Cephalalgia : an international journal of headache 2026-08-16 19:22:04 | Source |
| Examining the molecular mechanisms of topiramate in alleviating insul… Migraine and Body Composition · PMID 38308786 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Migraine, a severely debilitating condition, may be effectively managed with topiramate, known for its migraine prevent… | Endocrine 2026-08-16 19:21:59 | Source |
| Head-motion-controlled video goggles: preliminary concept for an inte… Static magnetic helmet · PMID 19670983 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Light-weight, low-profile, and high-resolution head-mounted displays (HMDs) now allow personalized viewing, of a laparo… | Journal of laparoendoscopic & advanced surgical techni… 2026-08-16 19:21:53 | Source |
| Real-World Characteristics and Treatment Patterns of Calcitonin Gene-… Fremanezumab · PMID 42098428 | Migraine | À vérifier | Publication | PubMed | Voir la publication source Understanding real-world calcitonin gene-related peptide monoclonal antibodies' (CGRP mAbs) use in patients with migrai… | Pain and therapy 2026-08-16 19:21:53 | Source |
| Randomized controlled trial of an oral CGRP receptor antagonist, MK-0… Telcagepant · PMID 17914062 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To determine an effective and tolerable dose of a novel oral calcitonin gene-related peptide (CGRP) receptor antagonist… | Neurology 2026-08-16 19:21:48 | Source |
| Analysis of the safety and efficacy of single-stage spinal cord stimu… SCS · PMID 42591884 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source To evaluate the safety and efficacy of implantation of a one-stage spinal cord stimulation (SCS) system under general a… | IBRO neuroscience reports 2026-08-16 19:21:47 | Source |
| circLDHC controls sertoli cell maturation and metabolic remodeling th… SCS · PMID 42492653 | Migraine | Thérapie génique | Publication | PubMed | Voir la publication source Sertoli cells (SCs) are crucial for testicular development, transitioning from a proliferative to a metabolically activ… | Molecular and cellular endocrinology 2026-08-16 19:21:47 | Source |
| Dopamine-modified TiCT MXene promotes supporting cell pluripotency an… SCS · PMID 42229301 | Migraine | Remyélinisation indirecte / réparation · Thérapie cellulaire | Publication | PubMed | Voir la publication source Sensorineural hearing loss (SNHL), predominantly resulting from the irreversible loss of cochlear hair cells, remains a… | Biomaterials 2026-08-16 19:21:47 | Source |
| Adjunctive middle meningeal artery embolization is associated with lo… Middle Meningeal Artery embolization · PMID 42190492 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate whether adjunctive middle meningeal artery (MMA) embolization is associated with lower 30-day readmission a… | Clinical neurology and neurosurgery 2026-08-16 19:21:46 | Source |
| A novel technique for middle meningeal artery embolization with proxi… Middle Meningeal Artery embolization · PMID 42595328 | Migraine | À vérifier | Publication | PubMed | Voir la publication source To evaluate single-operator outcomes of a standardized proximal Middle Meningeal Artery Embolization (MMAE) technique u… | Journal of cerebrovascular and endovascular neurosurge… 2026-08-16 19:21:46 | Source |
| Glucagon-Like Peptide-1 Receptor Agonists for Patients with Conservat… Middle Meningeal Artery embolization · PMID 42599090 | Migraine | Traitement symptomatique | Publication | PubMed | Voir la publication source Medical management options for nontraumatic subdural hematoma (SDH) remain limited, with only atorvastatin demonstratin… | Neurosurgery 2026-08-16 19:21:46 | Source |
| Halting neuron-fibroblast crosstalk disarms tumor and augments immuno… Rimegepant · PMID 42067475 | Migraine | Ralentissement de la progression | Publication | PubMed | Voir la publication source Innervation propels tumor progression through intricate mechanisms. Recently, Zhang et al. demonstrated that sensory ne… | Trends in pharmacological sciences 2026-08-16 19:21:43 | Source |
| Novel Application of UHPLC-MS, HRMS, and 2D-NMR for Structural Elucid… eletriptan · PMID 41507031 | Migraine | Neuroprotection | Publication | PubMed | Voir la publication source A stability-indicating UHPLC-MS method was developed to investigate the stress degradation behavior of eletriptan hydro… | Biomedical chromatography : BMC 2026-08-16 19:21:42 | Source |
| Treatment with eptinezumab for migraine prevention in people with chr… ALD403 · PMID 37357842 | Migraine | À vérifier | Publication | PubMed | Voir la publication source This is a summary of three articles describing preventive treatment of migraine in participants with a diagnosis of bot… | Pain management 2026-08-16 19:21:41 | Source |
Exploration — prudence
Pistes exploratoires 5
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Bavisant BRAVEinMS — Bavisant | Migraine | Remyélinisation · Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Antagonisme du récepteur H3 de l’histamine Bavisant est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migra… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| Tol-MP Tol-MP — tolérance immunitaire spécifique de la myéline | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Microparticules biodégradables chargées en rapamycine et fonctionnalisées… Tol-MP est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pour Migrain… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| SetPoint System SetPoint System — SetPoint Medical | Migraine | Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | re ApplicationsPublicationsCompanyCareersNewsGet startedGet startedNewsThe… SetPoint System est étudié dans Sclérose en plaques et documente plusieurs axes biologiques pouvant être pertinents pou… | Rapprochement Biomedical Watch · Sclérose en plaques | Détail |
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Migraine | Neuroprotection · Immunomodulation | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation immunométabolique de la microglie 4-octyl itaconate et dérivés est étudié dans Sclérose latérale amyotrophique et documente plusieurs axes biologiques po… | Rapprochement Biomedical Watch · Sclérose latérale amy… | Détail |
| N-PPG N-PPG — modulation métabolique cérébrale | Migraine | Remyélinisation indirecte / réparation · Neuroprotection | Hypothèse exploratoire | Rapprochement automatique non validé | Modulation métabolique et mitohormèse N-PPG est étudié dans Maladie de Huntington et documente plusieurs axes biologiques pouvant être pertinents pour Migrai… | Rapprochement Biomedical Watch · Maladie de Huntington | Détail |